Yahoo Web Search

Search results

1. • 

     fiercebiotech.com

     • Celgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid (lenalidomide), which is used in the treatment of multiple myeloma, and also in certain anemias.
     en.wikipedia.org › wiki › Celgene

     Celgene - Wikipedia

2. www.revlimid.comREVLIMID® (lenalidomide) - Official Patient Website

   www.revlimid.com

   • Cached

   REVLIMID is a prescription medicine, used to treat adults with multiple myeloma (MM) in combination with the medicine dexamethasone, or as maintenance treatment after autologous hematopoietic stem cell transplantation (a type of stem cell transplant that uses your own stem cells).

   • Living With Multiple Myeloma

     REVLIMID ® (lenalidomide) is a prescription medicine, used...

   • Treating multiple myeloma with REVLIMID

     REVLIMID is a prescription medicine used to treat adults...

3. People also ask

   Does Celgene have a pregnancy exposure registry?

   • Celgene Corporation at - - - . There is a pregnancy exposure registry that monitors the outcomes of females who take REVLIMID during pregnancy, or if their male partner takes REVLIMID and they are exposed during pregnancy. You can enroll in this registry by calling Celgene Corporation at the phone number listed above.

   Treating multiple myeloma with REVLIMID

   media.revlimid.com/wp-content/uploads/2020/01/US-REV-19-0673-REVLIMID-Treatment-Overview-Brochure.pdf

   See all results for this question

   Does Revlimid cause cancer?

   • Risk of new cancers (malignancies). People with multiple myeloma who receive melphalan (a type of chemotherapy) and a blood stem cell transplant with the addition of REVLIMID have a higher risk of developing new cancers, including certain blood cancers (acute myelogenous leukemia or AML) and a type of lymphoma called Hodgkin lymphoma.

   Reference ID: 3319577 - Food and Drug Administration

   www.accessdata.fda.gov/drugsatfda_docs/label/2013/021880s034lbl.pdf

   See all results for this question

   Where can I find information about Revlimid?

   • ), visit REVLIMID.com.Please see REVLIMID Important Safety Information throughout and on pages 2-30, as well as full Prescribing Information, including Boxed WARNING and Medication Guide.REVLIMID®, REVLIMID REMS®, and Celgene Patient Support® are registered trademarks of Celgene Corporation, a Bristo

   My Disease & Treatment - REVLIMID® (lenalidomide) Patient Site

   media.revlimid.com/wp-content/uploads/2021/01/Revlimid-My-Disease-and-Treatment-Brochure-US-REV-20-0041.pdf

   See all results for this question

   Is Revlimid approved by the Food & Drug Administration?

   • This Medication Guide has been approved by the U.S. Food and Drug Administration. Manufactured for: Celgene Corporation Summit, NJ 07901 REVLIMID®, RevAssist®, and THALOMID® are registered trademarks of Celgene Corporation. REVLIMID REMSTM is a trademark of Celgene Corporation.

   Reference ID: 3319577 - Food and Drug Administration

   www.accessdata.fda.gov/drugsatfda_docs/label/2013/021880s034lbl.pdf

   See all results for this question

4. www.revlimidhcp.comMultiple Myeloma Treatment Option | REVLIMID® (lenalidomide)

   www.revlimidhcp.com

   • Cached

   REVLIMID ® (lenalidomide) in combination with dexamethasone (dex) is indicated for the treatment of adult patients with multiplemyeloma (MM). REVLIMID is indicated as maintenance therapy in adult patients with MM following autologous hematopoietic stem celltransplantation (auto-HSCT).

5. media.revlimid.com › wp-content › uploadsMy Disease & Treatment - REVLIMID® (lenalidomide) Patient Site

   media.revlimid.com › wp-content › uploads

   REVLIMID is a prescription medicine used to treat adults with multiple myeloma (MM) in combination with the medicine dexamethasone, or as maintenance treatment after autologous hematopoietic stem cell transplantation (a type of stem cell transplant that uses your own stem cells).

6. www.accessdata.fda.gov › drugsatfda_docs › labelREVLIMID [lenalidomide] capsules, for oral use

   www.accessdata.fda.gov › drugsatfda_docs › label

   REVLIMID is indicated for the treatment of patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic...

   • File Size: 313KB

   • Page Count: 33

7. media.revlimid.com › wp-content › uploadsTreating multiple myeloma with REVLIMID

   media.revlimid.com › wp-content › uploads

   REVLIMID is a prescription medicine used to treat adults with: • multiple myeloma (MM) in combination with the medicine dexamethasone, or. as maintenance treatment after autologous hematopoietic stem cell transplantation (a type of stem cell transplant that uses your own stem cells).

   • File Size: 898KB

   • Page Count: 35

8. media.revlimid.com › wp-content › uploadsTAKE YOUR NEXT STEP WITH REVLIMID

   media.revlimid.com › wp-content › uploads

   – Celgene Corporation at 1-888-423-5436. There is a pregnancy exposure registry that monitors the outcomes of females who take REVLIMID during pregnancy, or if their male partner takes REVLIMID and they are exposed during pregnancy. You can enroll in this registry by calling Celgene Corporation at the phone number listed above.

9. medlibrary.org › lib › rxRevlimid (Celgene Corporation): FDA Package Insert

   medlibrary.org › lib › rx

   • Cached

   Mar 24, 2023 · REVLIMID is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.